128 related articles for article (PubMed ID: 38426219)
21. Different polycomb group CBX family proteins associate with distinct regions of chromatin using nonhomologous protein sequences.
Vincenz C; Kerppola TK
Proc Natl Acad Sci U S A; 2008 Oct; 105(43):16572-7. PubMed ID: 18927235
[TBL] [Abstract][Full Text] [Related]
22. Nonredundant and locus-specific gene repression functions of PRC1 paralog family members in human hematopoietic stem/progenitor cells.
van den Boom V; Rozenveld-Geugien M; Bonardi F; Malanga D; van Gosliga D; Heijink AM; Viglietto G; Morrone G; Fusetti F; Vellenga E; Schuringa JJ
Blood; 2013 Mar; 121(13):2452-61. PubMed ID: 23349393
[TBL] [Abstract][Full Text] [Related]
23. Selective Inhibition of CBX6: A Methyllysine Reader Protein in the Polycomb Family.
Milosevich N; Gignac MC; McFarlane J; Simhadri C; Horvath S; Daze KD; Croft CS; Dheri A; Quon TT; Douglas SF; Wulff JE; Paci I; Hof F
ACS Med Chem Lett; 2016 Feb; 7(2):139-44. PubMed ID: 26985288
[TBL] [Abstract][Full Text] [Related]
24. CBX8 promotes lung adenocarcinoma growth and metastasis through transcriptional repression of CDKN2C and SCEL.
Chen H; Su Y; Yang L; Xi L; Li X; Lan B; Liu M; Xuan C
J Cell Physiol; 2023 Nov; 238(11):2710-2723. PubMed ID: 37733753
[TBL] [Abstract][Full Text] [Related]
25. PRC2.1- and PRC2.2-specific accessory proteins drive recruitment of different forms of canonical PRC1.
Glancy E; Wang C; Tuck E; Healy E; Amato S; Neikes HK; Mariani A; Mucha M; Vermeulen M; Pasini D; Bracken AP
Mol Cell; 2023 May; 83(9):1393-1411.e7. PubMed ID: 37030288
[TBL] [Abstract][Full Text] [Related]
26. Prognostic and immune infiltrates for the Chromobox (CBX) protein family in human pancreatic adenocarcinoma.
Li Q; Fu L; Wu D; Wang J
J Gastrointest Oncol; 2021 Oct; 12(5):2310-2324. PubMed ID: 34790394
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive Analysis of the Expression and Prognosis Value of Chromobox Family Members in Clear Cell Renal Cell Carcinoma.
Zhu Y; Pu Z; Li Z; Lin Y; Li N; Peng F
Front Oncol; 2021; 11():700528. PubMed ID: 34395271
[TBL] [Abstract][Full Text] [Related]
28. Identification of the Roles of Chromobox Family Members in Gastric Cancer: A Study Based on Multiple Datasets.
Chen ZY; Sun SX; Zhu SX; Bu J
Biomed Res Int; 2020; 2020():5306509. PubMed ID: 33344640
[TBL] [Abstract][Full Text] [Related]
29. Beyond EZH2: is the polycomb protein CBX2 an emerging target for anti-cancer therapy?
Jangal M; Lebeau B; Witcher M
Expert Opin Ther Targets; 2019 Jul; 23(7):565-578. PubMed ID: 31177918
[No Abstract] [Full Text] [Related]
30. Nuclear condensates of the Polycomb protein chromobox 2 (CBX2) assemble through phase separation.
Tatavosian R; Kent S; Brown K; Yao T; Duc HN; Huynh TN; Zhen CY; Ma B; Wang H; Ren X
J Biol Chem; 2019 Feb; 294(5):1451-1463. PubMed ID: 30514760
[TBL] [Abstract][Full Text] [Related]
31. Mining database for the clinical significance and prognostic value of CBX family in skin cutaneous melanoma.
Li D; Liu Y; Hao S; Chen B; Li A
J Clin Lab Anal; 2020 Dec; 34(12):e23537. PubMed ID: 32860274
[TBL] [Abstract][Full Text] [Related]
32. The predictive significance of chromobox family members in prostate cancer in humans.
Xu X; Lai C; Luo J; Shi J; Guo K; Hu J; Mulati Y; Xiao Y; Kong D; Liu C; Huang J; Xu K
Cell Oncol (Dordr); 2024 Mar; ():. PubMed ID: 38427207
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive analysis reveals the value of the expression of chromobox family members for bladder urothelial carcinoma prognosis.
Meng X; Cao R; Liu X; Fu B; Luo L; Jiang M; Wang K; Liu Y; Zhu Q; Yang C; Zhou L
Oncol Lett; 2023 Apr; 25(4):172. PubMed ID: 36970607
[TBL] [Abstract][Full Text] [Related]
34. A Potent, Selective CBX2 Chromodomain Ligand and Its Cellular Activity During Prostate Cancer Neuroendocrine Differentiation.
Wang S; Alpsoy A; Sood S; Ordonez-Rubiano SC; Dhiman A; Sun Y; Jiao G; Krusemark CJ; Dykhuizen EC
Chembiochem; 2021 Jul; 22(13):2335-2344. PubMed ID: 33950564
[TBL] [Abstract][Full Text] [Related]
35. Subcellular expression pattern and clinical significance of CBX2 and CBX7 in breast cancer subtypes.
Park S; Choi J; Song JK; Jang B; Maeng YH
Med Mol Morphol; 2024 Mar; 57(1):11-22. PubMed ID: 37553450
[TBL] [Abstract][Full Text] [Related]
36. Novel chromobox 2 inhibitory peptide decreases tumor progression.
Brubaker LW; Backos DS; Nguyen VT; Reigan P; Yamamoto TM; Woodruff ER; Iwanaga R; Wempe MF; Kumar V; Persenaire C; Watson ZL; Bitler BG
Expert Opin Ther Targets; 2023; 27(4-5):361-371. PubMed ID: 37243607
[TBL] [Abstract][Full Text] [Related]
37. Cbx2 stably associates with mitotic chromosomes via a PRC2- or PRC1-independent mechanism and is needed for recruiting PRC1 complex to mitotic chromosomes.
Zhen CY; Duc HN; Kokotovic M; Phiel CJ; Ren X
Mol Biol Cell; 2014 Nov; 25(23):3726-39. PubMed ID: 25232004
[TBL] [Abstract][Full Text] [Related]
38. PRC1 complex diversity: where is it taking us?
Gil J; O'Loghlen A
Trends Cell Biol; 2014 Nov; 24(11):632-41. PubMed ID: 25065329
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive Analysis of the Expression and Prognosis of chromobox Family Members in Breast Cancer.
Wang L; Zhao L; Zhang Y; Shao S; Ning Q; Zhao X; Luo M
Clin Breast Cancer; 2023 Jun; 23(4):e206-e218. PubMed ID: 36890004
[TBL] [Abstract][Full Text] [Related]
40. CBX7 Induces Self-Renewal of Human Normal and Malignant Hematopoietic Stem and Progenitor Cells by Canonical and Non-canonical Interactions.
Jung J; Buisman SC; Weersing E; Dethmers-Ausema A; Zwart E; Schepers H; Dekker MR; Lazare SS; Hammerl F; Skokova Y; Kooistra SM; Klauke K; Poot RA; Bystrykh LV; de Haan G
Cell Rep; 2019 Feb; 26(7):1906-1918.e8. PubMed ID: 30759399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
